Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adverum Biotechnlgs (NQ: ADVM )

3.580 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,160
Open 3.580
Bid (Size) 3.550 (10)
Ask (Size) 3.650 (11)
Prev. Close 3.580
Today's Range 3.580 - 3.580
52wk Range 3.460 - 26.98
Shares Outstanding 97,934,777
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. ("Adverum" or the "Company") (NASDAQ: ADVM). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire

Performance

YTD
-70.12%
-70.12%
1 Month
-60.04%
-60.04%
3 Month
-73.36%
-73.36%
6 Month
-70.07%
-70.07%
1 Year
-80.10%
-80.10%

More News

Read More
Adverum Issues Statement Regarding Upcoming Annual Meeting of Stockholders
From GlobeNewswire News Releases
The Sonic Fund II, L.P. Comments on Preliminary Voting Results of Adverum Annual Meeting
From Business Wire News Releases
Adverum Reports First Quarter 2021 Results
From GlobeNewswire News Releases
The Sonic Fund II, L.P. Issues Statement to Adverum Stockholders
From Business Wire News Releases
The Sonic Fund II, L.P. Reminds Adverum Stockholders to Vote for Its Three Independent Director Nominees at May 12 Annual Meeting
From Business Wire News Releases
Glass Lewis Joins ISS In Recommending Adverum Shareholders Vote for All Three Independent Sonic Director Nominees
From Business Wire News Releases
Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-experienced Wet AMD Patients at ARVO 2021
From GlobeNewswire News Releases
MOON's Holdings Could Mean 45% Gain Potential
Tags ETFs
From ETF Channel
ISS Recommends Adverum Stockholders Vote to Elect Sonic’s Three Independent, Highly Qualified Nominees
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.